Clinical observations
Architecture is LOINC-ready for standardised laboratory and clinical observation identifiers.
This layer models laboratory and clinical observations, imaging capabilities, pathology, microbiology and diagnostic services as separate entities connected to diseases, organisations and evidence.
Architecture is LOINC-ready for standardised laboratory and clinical observation identifiers.
MRI, CT, PET, ultrasound and specialty imaging are mapped as capabilities with organisation-level verification.
Capability Registry →Histopathology, molecular pathology and specimen-dependent services remain distinct.
PCR, culture, serology and molecular diagnostics link pathogens, diseases and lab capabilities.
Infectious disease →Genetic and genomic capabilities connect to phenotype, oncology, rare disease and pharmacogenomic pathways.
Genomics layer →Disease Intelligence can explain what a test or capability is; clinical interpretation remains appropriately governed.
Safety model →